Medicine
Cysview kit
Cysview kit is a prescription medicine containing Hexaminolevulinate, marketed by Photocure, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Alternatively, the solution may be stored in the labeled syringe under…
Key facts
- Active ingredient (INN)
- Hexaminolevulinate
- Brand
- Cysview
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Photocure
- Manufacturer
- Photocure
- Origin register
- US FDA, United States
- Storage
- Alternatively, the solution may be stored in the labeled syringe under refrigeration at 2°C to 8°C (36°F to 46°F) for up to 2 hours. Store the CYSVIEW kit at 20°C to 25°C (68°F to 77°F), excursions are permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 May 2018
- Identifiers
- DailyMed set ID 5aeed40d-6841-4adf-8940-f51d439fdfa3NDC 10511-3001Application NDA022555
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 50 mL in 1 syringe, plastic * 50 mL in 1 vial, glass | 10511-3001-2 | Photocure | 1 May 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 May 2010 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Hexaminolevulinate is a prescription medicine indicated for the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), in adult patients. It is available as kits. MedsAcross supplies Hexaminolevulinate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HexaminolevulinateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cysview prescribing information (Photocure) · U.S. National Library of Medicine, DailyMed
Need Cysview kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.